Appellate Tribunal Allows Amalgamation Scheme, Emphasizes Companies Act Compliance

The Appellate Tribunal overturned the decision of the lower Tribunal and directed the National Company Law Tribunal, Hyderabad Bench, to sanction the Scheme of Amalgamation between the appellant companies. The Appellate Tribunal emphasized that private limited companies can issue shares at a premium under the Companies Act, 2013, and that the companies had complied with all statutory provisions and accounting standards. The appeal was allowed, with no order as to costs.

---

---

Issues Involved:
1. Whether the Tribunal erred in not sanctioning the Scheme of Amalgamation between the appellant companies.
2. Whether private limited companies can issue shares at a premium under the Companies Act, 2013.
3. Compliance with statutory provisions and accounting standards for the Scheme of Amalgamation.

Issue-wise Detailed Analysis:

1. Tribunal's Refusal to Sanction the Scheme of Amalgamation:
The appellants filed a joint petition for the sanction of the Scheme of Amalgamation between Ritemed Pharma Retail Private Limited and Optival Health Solutions Private Limited. The Tribunal, however, disinclined to sanction the scheme on the grounds that both companies are unlisted/private limited companies and there is no explicit provision in the Companies Act, 2013 allowing the issuance of shares at a premium for such companies. The Tribunal's decision was based on the absence of explicit provisions in the Companies Act, 2013, and the reliance on a previous High Court order that involved listed companies, which the Tribunal deemed not applicable to the present case.

2. Issuance of Shares at a Premium by Private Limited Companies:
The appellants argued that there is no legal prohibition against issuing shares at a premium for private companies under the Companies Act, 2013. Section 52 of the Companies Act, 2013 specifically provides for the issuance of shares at a premium, whether for cash or otherwise. The appellants cited several judgments where courts permitted the issuance of shares at a premium as part of a Scheme of Amalgamation, arguing that the Act does not differentiate between listed and private companies in this regard.

3. Compliance with Statutory Provisions and Accounting Standards:
The appellants contended that they had complied with all statutory requirements for the Scheme of Amalgamation, including obtaining approvals from relevant stakeholders such as the Board of Directors and creditors. They also submitted a certificate from their auditor confirming that the accounting treatment proposed in the scheme conformed to applicable accounting standards, as required under Section 232(3)(i) of the Companies Act, 2013. The appellants argued that the Tribunal should not have rejected the scheme based on an unfounded belief regarding the issuance of shares at a premium.

Appellate Tribunal's Findings:
The Appellate Tribunal observed that Section 232(3)(i) of the Companies Act, 2013 is applicable to all companies, regardless of whether they are private or public, listed or unlisted. The Tribunal emphasized that the issuance of shares at a premium is permissible under Section 52 of the Companies Act, 2013, and that the companies had complied with all necessary legal and accounting requirements. The Tribunal also referred to the Supreme Court's judgment in Miheer H. Mafatlal Vs Mafatlal Industries Ltd, which outlined the scope and ambit of the jurisdiction of the Company Court in approving schemes of amalgamation.

Conclusion:
The Appellate Tribunal concluded that the Tribunal's refusal to sanction the Scheme of Amalgamation was not justified. The Tribunal directed the National Company Law Tribunal, Hyderabad Bench, to sanction the scheme and issue further consequential directions/orders to ensure legal compliance. The appeal was allowed, and no order as to costs was made.

---